Benzyl 3-(2-oxoethyl)piperidine-1-carboxylate

Catalog No.: 
ACWZNX936
CAS No.: 
372159-77-8
Molecular Formula: 
C15H19NO3
Molecular Weight: 
261.32
Benzyl 3-(2-oxoethyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$124.00InquiryInquiry
250mg97%$200.00InquiryInquiry
1g97%$398.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 3-(2-oxoethyl)piperidine-1-carboxylate
IUPAC Namebenzyl 3-(2-oxoethyl)piperidine-1-carboxylate
MDL No.MFCD03425261
Molecular FormulaC15H19NO3
Molecular Weight261.32
SMILESO=C(N1CC(CC=O)CCC1)OCC2=CC=CC=C2
InChI KeyCNEFTNPXPQDBGA-UHFFFAOYSA-N
SynonymN-CBZ-PIPERIDINYL-3-ACETALDEHYDE;3-(2-OXO-ETHYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER;1-CBZ-3-(2-OXO-ETHYL)-PIPERIDINE;Benzyl 3-(2-oxoethyl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-(2-oxoethyl)-, phenylmethyl ester;N-CBZ-3-piperidineacetaldehyde
CAS No.372159-77-8
PubChem CID44784970

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWZNX936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEGTL094 route compound structure diagram
    ACEGTL09486827-10-3In Stock
  2. Then
  3. ACWZNX936 route product structure diagram
    ACWZNX936372159-77-8
Inquiry

2. ACWZNX936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZNX936 route product structure diagram
    ACWZNX936372159-77-8
Inquiry

3. ACWZNX936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZNX936 route product structure diagram
    ACWZNX936372159-77-8
Inquiry

Comments (0)